APA
Selim, D. S. M. R. S. D. S. D. T. H. D. L. D. (2022). Comparison of Compliance and Treatment Delay Between Paclitaxel and Carboplatin Regimen Versus Gemcitabine and Carboplatin Regimen as Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Quasi-Experimental Study. International Journal of Medical and Pharmaceutical Research, 3(2), 0-0.
MLA
Selim, Dr. S. M. R. S. D. S. D. T. H. D. L. D.. "Comparison of Compliance and Treatment Delay Between Paclitaxel and Carboplatin Regimen Versus Gemcitabine and Carboplatin Regimen as Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Quasi-Experimental Study." International Journal of Medical and Pharmaceutical Research 3.2 (2022): 0-0.
Chicago
Selim, Dr. S. M. R. S. D. S. D. T. H. D. L. D.. "Comparison of Compliance and Treatment Delay Between Paclitaxel and Carboplatin Regimen Versus Gemcitabine and Carboplatin Regimen as Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Quasi-Experimental Study." International Journal of Medical and Pharmaceutical Research 3, no. 2 (2022): 0-0.
Harvard
Selim, D. S. M. R. S. D. S. D. T. H. D. L. D. (2022) 'Comparison of Compliance and Treatment Delay Between Paclitaxel and Carboplatin Regimen Versus Gemcitabine and Carboplatin Regimen as Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Quasi-Experimental Study' International Journal of Medical and Pharmaceutical Research 3(2), pp. 0-0.
Vancouver
Selim DSMRSDSDTHDLD. Comparison of Compliance and Treatment Delay Between Paclitaxel and Carboplatin Regimen Versus Gemcitabine and Carboplatin Regimen as Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Quasi-Experimental Study. International Journal of Medical and Pharmaceutical Research. 2022 ;3(2):0-0.